Will UnitedHealth Stock Recover?
Shares of embattled health insurance giant UnitedHealth (NYSE:UNH) plummeted by…
Sell
47
SFBC Quote, Financials, Valuation and Earnings
Last price:
$43.66
Seasonality move
:
3.67%
Day range:
$43.94 - $44.21
52-week range:
$42.75 - $52.13
Dividend yield:
1.77%
P/E ratio:
15.92x
P/S ratio:
1.84x
P/B ratio:
0.96x
Volume:
4.1K
Avg. volume:
4.8K
1-year change:
-14.54%
Market cap:
$105.3M
Revenue:
$61.6M
EPS (TTM):
$2.77
| Period Ending | 2021-12-31 | 2022-12-31 | 2023-12-31 | 2024-12-31 | 2025-12-31 | |
|---|---|---|---|---|---|---|
| Revenue | $41.2M | $44.4M | $55.6M | $62.1M | $61.6M | |
| Revenue Growth (YoY) | -2.76% | 7.66% | 25.3% | 11.62% | -0.71% | |
| Cost of Revenues | -- | -- | -- | -- | -- | |
| Gross Profit | -- | -- | -- | -- | -- | |
| Gross Profit Margin | -- | -- | -- | -- | -- | |
| R&D Expenses | -- | -- | -- | -- | -- | |
| Selling, General & Admin | -- | -- | -- | -- | -- | |
| Other Inc / (Exp) | -- | -- | -- | -- | -- | |
| Operating Expenses | -$11.4M | -$10.9M | -$9M | -$5.6M | -$8.7M | |
| Operating Income | $11.4M | $10.9M | $9M | $5.6M | $8.7M | |
| Net Interest Expenses | $672K | $1.6M | $2.6M | $2.3M | $1.7M | |
| EBT. Incl. Unusual Items | $11.4M | $10.9M | $9M | $5.6M | $8.7M | |
| Earnings of Discontinued Ops. | -- | -- | -- | -- | -- | |
| Income Tax Expense | $2.3M | $2.1M | $1.6M | $1M | $1.5M | |
| Net Income to Company | $9.2M | $8.8M | $7.4M | $4.6M | -- | |
| Minority Interest in Earnings | -- | -- | -- | -- | -- | |
| Net Income to Common Excl Extra Items | $9.2M | $8.8M | $7.4M | $4.6M | $7.2M | |
| Basic EPS (Cont. Ops) | $3.55 | $3.41 | $2.89 | $1.81 | $2.78 | |
| Diluted EPS (Cont. Ops) | $3.49 | $3.37 | $2.86 | $1.80 | $2.77 | |
| Weighted Average Basic Share | $2.6M | $2.6M | $2.6M | $2.5M | -- | |
| Weighted Average Diluted Share | $2.6M | $2.6M | $2.6M | $2.6M | -- | |
| EBITDA | -- | $17M | $27.4M | $33.6M | -- | |
| EBIT | $15.4M | $15.4M | $25.8M | $32M | $31.3M | |
| Revenue (Reported) | $41.2M | $44.4M | $55.6M | $62.1M | $61.6M | |
| Operating Income (Reported) | $11.4M | $10.9M | $9M | $5.6M | $8.7M | |
| Operating Income (Adjusted) | $15.4M | $15.4M | $25.8M | $32M | $31.3M | |
| Period Ending | 2021-12-31 | 2022-12-31 | 2023-12-31 | 2024-12-31 | 2025-12-31 | |
|---|---|---|---|---|---|---|
| Revenue | $9.8M | $12.8M | $14.4M | $15.9M | $15.3M | |
| Revenue Growth (YoY) | -19.08% | 30.43% | 12.2% | 10.51% | -4.06% | |
| Cost of Revenues | -- | -- | -- | -- | -- | |
| Gross Profit | -- | -- | -- | -- | -- | |
| Gross Profit Margin | -- | -- | -- | -- | -- | |
| R&D Expenses | -- | -- | -- | -- | -- | |
| Selling, General & Admin | -- | -- | -- | -- | -- | |
| Other Inc / (Exp) | -- | -- | -- | -- | -- | |
| Operating Expenses | -$2.3M | -$3.5M | -$1.4M | -$2.3M | -$2.6M | |
| Operating Income | $2.3M | $3.5M | $1.4M | $2.3M | $2.6M | |
| Net Interest Expenses | $168K | $752K | $599K | $499K | $420K | |
| EBT. Incl. Unusual Items | $2.3M | $3.5M | $1.4M | $2.3M | $2.6M | |
| Earnings of Discontinued Ops. | -- | -- | -- | -- | -- | |
| Income Tax Expense | $407K | $539K | $143K | $389K | $339K | |
| Net Income to Company | $1.9M | $2.9M | $1.2M | $1.9M | -- | |
| Minority Interest in Earnings | -- | -- | -- | -- | -- | |
| Net Income to Common Excl Extra Items | $1.9M | $2.9M | $1.2M | $1.9M | $2.2M | |
| Basic EPS (Cont. Ops) | $0.72 | $1.14 | $0.47 | $0.75 | $0.88 | |
| Diluted EPS (Cont. Ops) | $0.71 | $1.12 | $0.47 | $0.74 | $0.87 | |
| Weighted Average Basic Share | $2.6M | $2.6M | $2.5M | $2.5M | $2.6M | |
| Weighted Average Diluted Share | $2.6M | $2.6M | $2.6M | $2.6M | $2.6M | |
| EBITDA | -- | -- | -- | -- | -- | |
| EBIT | $2.9M | $5.6M | $7.1M | $8.8M | $8.2M | |
| Revenue (Reported) | $9.8M | $12.8M | $14.4M | $15.9M | $15.3M | |
| Operating Income (Reported) | $2.3M | $3.5M | $1.4M | $2.3M | $2.6M | |
| Operating Income (Adjusted) | $2.9M | $5.6M | $7.1M | $8.8M | $8.2M | |
| Period Ending | 2021-12-31 | 2022-12-31 | 2023-12-31 | 2024-12-31 | 2025-12-31 | |
|---|---|---|---|---|---|---|
| Revenue | $41.2M | $44.4M | $55.6M | $62.1M | $61.6M | |
| Revenue Growth (YoY) | -- | -- | -- | -- | -- | |
| Cost of Revenues | -- | -- | -- | -- | -- | |
| Gross Profit | -- | -- | -- | -- | -- | |
| Gross Profit Margin | -- | -- | -- | -- | -- | |
| R&D Expenses | -- | -- | -- | -- | -- | |
| Selling, General & Admin | -- | -- | -- | -- | -- | |
| Other Inc / (Exp) | -- | -- | -- | -- | -- | |
| Operating Expenses | -$11.4M | -$10.9M | -$9M | -$5.6M | -$7.7M | |
| Operating Income | $11.4M | $10.9M | $9M | $5.6M | $7.7M | |
| Net Interest Expenses | $672K | $1.5M | $2.6M | $2.3M | $1.7M | |
| EBT. Incl. Unusual Items | $11.4M | $10.9M | $9M | $5.6M | $8.7M | |
| Earnings of Discontinued Ops. | -- | -- | -- | -- | -- | |
| Income Tax Expense | $2.3M | $2.1M | $1.6M | $1M | $1.5M | |
| Net Income to Company | $9.2M | $8.8M | $7.4M | $4.6M | -- | |
| Minority Interest in Earnings | -- | -- | -- | -- | -- | |
| Net Income to Common Excl Extra Items | $9.2M | $8.8M | $7.4M | $4.6M | $7.2M | |
| Basic EPS (Cont. Ops) | $3.55 | $3.42 | $2.88 | $1.81 | $2.79 | |
| Diluted EPS (Cont. Ops) | $3.49 | $3.37 | $2.86 | $1.79 | $2.77 | |
| Weighted Average Basic Share | ||||||
| Weighted Average Diluted Share | ||||||
| EBITDA | -- | -- | -- | -- | -- | |
| EBIT | $15.4M | $15.4M | $25.8M | $32M | $31.3M | |
| Revenue (Reported) | $41.2M | $44.4M | $55.6M | $62.1M | $61.6M | |
| Operating Income (Reported) | $11.4M | $10.9M | $9M | $5.6M | $7.7M | |
| Operating Income (Adjusted) | $15.4M | $15.4M | $25.8M | $32M | $31.3M | |
| Period Ending | 2022-12-31 | 2023-12-31 | 2024-12-31 | 2025-12-31 | 2026-12-31 | |
|---|---|---|---|---|---|---|
| Revenue | $44.4M | $55.6M | $62.1M | $61.6M | -- | |
| Revenue Growth (YoY) | -- | -- | -- | -- | -- | |
| Cost of Revenues | -- | -- | -- | -- | -- | |
| Gross Profit | -- | -- | -- | -- | -- | |
| Gross Profit Margin | -- | -- | -- | -- | -- | |
| R&D Expenses | -- | -- | -- | -- | -- | |
| Selling, General & Admin | -- | -- | -- | -- | -- | |
| Other Inc / (Exp) | -- | -- | -- | -- | -- | |
| Operating Expenses | -$10.9M | -$9M | -$5.6M | -$7.7M | -- | |
| Operating Income | $10.9M | $9M | $5.6M | $7.7M | -- | |
| Net Interest Expenses | $1.5M | $2.6M | $2.3M | $1.7M | -- | |
| EBT. Incl. Unusual Items | $10.9M | $9M | $5.6M | $8.7M | -- | |
| Earnings of Discontinued Ops. | -- | -- | -- | -- | -- | |
| Income Tax Expense | $2.1M | $1.6M | $1M | $1.5M | -- | |
| Net Income to Company | $8.8M | $7.4M | $4.6M | $1.2M | -- | |
| Minority Interest in Earnings | -- | -- | -- | -- | -- | |
| Net Income to Common Excl Extra Items | $8.8M | $7.4M | $4.6M | $7.2M | -- | |
| Basic EPS (Cont. Ops) | $3.42 | $2.88 | $1.81 | $2.79 | -- | |
| Diluted EPS (Cont. Ops) | $3.37 | $2.86 | $1.79 | $2.77 | -- | |
| Weighted Average Basic Share | $10.3M | $10.2M | $10.2M | $10.2M | -- | |
| Weighted Average Diluted Share | $10.5M | $10.3M | $10.3M | $10.3M | -- | |
| EBITDA | $3M | $5.9M | $7.6M | $7.5M | -- | |
| EBIT | $15.4M | $25.8M | $32M | $31.3M | -- | |
| Revenue (Reported) | $44.4M | $55.6M | $62.1M | $61.6M | -- | |
| Operating Income (Reported) | $10.9M | $9M | $5.6M | $7.7M | -- | |
| Operating Income (Adjusted) | $15.4M | $25.8M | $32M | $31.3M | -- | |
| Period Ending | 2021-12-31 | 2022-12-31 | 2023-12-31 | 2024-12-31 | 2025-12-31 | |
|---|---|---|---|---|---|---|
| Cash and Equivalents | $183.6M | $57.8M | $49.7M | $43.6M | $138.5M | |
| Short Term Investments | $8.4M | $10.2M | $8.3M | $7.8M | -- | |
| Accounts Receivable, Net | $2.2M | $3.1M | $3.5M | $3.5M | -- | |
| Inventory | -- | -- | -- | -- | -- | |
| Prepaid Expenses | -- | -- | -- | -- | -- | |
| Other Current Assets | -- | -- | -- | -- | -- | |
| Total Current Assets | $186.5M | $61.6M | $53.7M | $47.1M | $142.6M | |
| Property Plant And Equipment | $11.6M | $10.6M | $9.7M | $8.4M | $7.7M | |
| Long-Term Investments | $4.1M | $2.8M | $3M | $2.2M | $1.6M | |
| Goodwill | -- | -- | -- | -- | -- | |
| Other Intangibles | $4.3M | $4.7M | $4.6M | $4.8M | -- | |
| Other Long-Term Assets | -- | -- | -- | -- | -- | |
| Total Assets | $919.7M | $976.4M | $995.2M | $993.6M | $1.1B | |
| Accounts Payable | $200K | $395K | $817K | $765K | -- | |
| Accrued Expenses | -- | -- | -- | -- | -- | |
| Current Portion Of Long-Term Debt | -- | $43M | $15M | -- | -- | |
| Current Portion Of Capital Lease Obligations | -- | -- | -- | -- | -- | |
| Other Current Liabilities | -- | -- | -- | -- | -- | |
| Total Current Liabilities | $590.4M | $547.3M | $715.5M | $756.8M | $591.9M | |
| Long-Term Debt | $16.9M | $16.1M | $40.4M | $39.7M | $21.5M | |
| Capital Leases | -- | -- | -- | -- | -- | |
| Total Liabilities | $826.3M | $878.6M | $894.6M | $890M | $982.8M | |
| Common Stock | $26K | $26K | $25K | $25K | $25K | |
| Other Common Equity Adj | $139K | -$1.1M | -$988K | -$1M | -- | |
| Common Equity | $93.4M | $97.7M | $100.7M | $103.7M | $109.4M | |
| Total Preferred Equity | -- | -- | -- | -- | -- | |
| Minority Interest, Total | -- | -- | -- | -- | -- | |
| Total Equity | $93.4M | $97.7M | $100.7M | $103.7M | $109.4M | |
| Total Liabilities and Equity | $919.7M | $976.4M | $995.2M | $993.6M | $1.1B | |
| Cash and Short Terms | $192M | $68M | $58M | $51.4M | -- | |
| Total Debt | $16.9M | $16.1M | $55.4M | $39.7M | $21.5M | |
| Period Ending | 2021-12-31 | 2022-12-31 | 2023-12-31 | 2024-12-31 | 2025-12-31 | |
|---|---|---|---|---|---|---|
| Cash and Equivalents | $183.6M | $57.8M | $49.7M | $43.6M | $138.5M | |
| Short Term Investments | $8.4M | $10.2M | $8.3M | $7.8M | -- | |
| Accounts Receivable, Net | $2.2M | $3.1M | $3.5M | $3.5M | -- | |
| Inventory | -- | -- | -- | -- | -- | |
| Prepaid Expenses | -- | -- | -- | -- | -- | |
| Other Current Assets | -- | -- | -- | -- | -- | |
| Total Current Assets | $186.5M | $61.6M | $53.7M | $47.1M | $142.6M | |
| Property Plant And Equipment | $11.6M | $10.6M | $9.7M | $8.4M | $7.7M | |
| Long-Term Investments | $4.1M | $2.8M | $3M | $2.2M | $1.6M | |
| Goodwill | -- | -- | -- | -- | -- | |
| Other Intangibles | $4.3M | $4.7M | $4.6M | $4.8M | -- | |
| Other Long-Term Assets | -- | -- | -- | -- | -- | |
| Total Assets | $919.7M | $976.4M | $995.2M | $993.6M | $1.1B | |
| Accounts Payable | $200K | $395K | $817K | $765K | -- | |
| Accrued Expenses | -- | -- | -- | -- | -- | |
| Current Portion Of Long-Term Debt | -- | $43M | $15M | -- | -- | |
| Current Portion Of Capital Lease Obligations | -- | -- | -- | -- | -- | |
| Other Current Liabilities | -- | -- | -- | -- | -- | |
| Total Current Liabilities | $590.4M | $547.3M | $715.5M | $756.8M | $591.9M | |
| Long-Term Debt | $16.9M | $16.1M | $40.4M | $39.7M | $21.5M | |
| Capital Leases | -- | -- | -- | -- | -- | |
| Total Liabilities | $826.3M | $878.6M | $894.6M | $890M | $982.8M | |
| Common Stock | $26K | $26K | $25K | $25K | $25K | |
| Other Common Equity Adj | $139K | -$1.1M | -$988K | -$1M | -- | |
| Common Equity | -- | -- | -- | -- | -- | |
| Total Preferred Equity | -- | -- | -- | -- | -- | |
| Minority Interest, Total | -- | -- | -- | -- | -- | |
| Total Equity | $93.4M | $97.7M | $100.7M | $103.7M | $109.4M | |
| Total Liabilities and Equity | $919.7M | $976.4M | $995.2M | $993.6M | $1.1B | |
| Cash and Short Terms | $192M | $68M | $58M | $51.4M | -- | |
| Total Debt | $16.9M | $16.1M | $55.4M | $39.7M | $21.5M | |
| Period Ending | 2020-12-31 | 2021-12-31 | 2022-12-31 | 2023-12-31 | 2024-12-31 | |
|---|---|---|---|---|---|---|
| Net Income to Stockholders | $8.9M | $9.2M | $8.8M | $7.4M | $4.6M | |
| Depreciation & Amoritzation | $1.8M | $1.6M | $1.6M | $1.7M | $1.6M | |
| Stock-Based Compensation | $338K | $360K | $475K | $450K | $390K | |
| Change in Accounts Receivable | -$48K | $37K | -$866K | -$369K | -$19K | |
| Change in Inventories | -- | -- | -- | -- | -- | |
| Cash From Operations | $6.4M | $7.7M | $8.4M | $7.3M | $3.9M | |
| Capital Expenditures | $464K | $6.3M | $398K | $444K | $43K | |
| Cash Acquisitions | -- | -- | -- | -- | -- | |
| Cash From Investing | -$2.4M | -$66.5M | -$183.9M | -$26.8M | -$3.9M | |
| Dividends Paid (Ex Special Dividend) | $2.1M | $2M | $2M | $1.9M | $1.9M | |
| Special Dividend Paid | ||||||
| Long-Term Debt Issued | $186.2M | -- | $43M | $40M | -- | |
| Long-Term Debt Repaid | -$181.8M | -- | -- | -$43M | -$15M | |
| Repurchase of Common Stock | $73K | $152K | $1.7M | $2.1M | $65K | |
| Other Financing Activities | -- | -- | -$1.8M | $436K | $666K | |
| Cash From Financing | $134M | $48.6M | $49.8M | $11.3M | -$6M | |
| Beginning Cash (CF) | $55.8M | $193.8M | $183.6M | $57.8M | $49.7M | |
| Foreign Exchange Rate Adjustment | -- | -- | -- | -- | -- | |
| Additions / Reductions | $138.1M | -$10.2M | -$125.8M | -$8.1M | -$6M | |
| Ending Cash (CF) | $193.8M | $183.6M | $57.8M | $49.7M | $43.6M | |
| Levered Free Cash Flow | $6M | $1.4M | $8M | $6.9M | $3.9M | |
| Period Ending | 2021-12-31 | 2022-12-31 | 2023-12-31 | 2024-12-31 | 2025-12-31 | |
|---|---|---|---|---|---|---|
| Net Income to Stockholders | $1.9M | $2.9M | $1.2M | $1.9M | -- | |
| Depreciation & Amoritzation | -- | -- | -- | -- | -- | |
| Stock-Based Compensation | $65K | $91K | $82K | $99K | -- | |
| Change in Accounts Receivable | $14K | -$274K | -$37K | $234K | -- | |
| Change in Inventories | -- | -- | -- | -- | -- | |
| Cash From Operations | $5.9M | $2.7M | $1.5M | $920K | -- | |
| Capital Expenditures | $86K | $173K | $219K | $18K | -- | |
| Cash Acquisitions | -- | -- | -- | -- | -- | |
| Cash From Investing | -$19.2M | -$14.2M | -$18.6M | $2M | -- | |
| Dividends Paid (Ex Special Dividend) | $445K | $440K | $488K | $489K | -- | |
| Special Dividend Paid | -- | -- | -- | -- | -- | |
| Long-Term Debt Issued | -- | -$1.5M | -$49K | -- | -- | |
| Long-Term Debt Repaid | $175K | $1.9M | -- | -$15M | -- | |
| Repurchase of Common Stock | $122K | -- | $738K | -- | -- | |
| Other Financing Activities | -- | -- | -- | -- | -- | |
| Cash From Financing | -$9.8M | -$6.7M | -$35.2M | -$108.2M | -- | |
| Beginning Cash (CF) | $206.7M | $76.1M | $101.9M | $148.9M | -- | |
| Foreign Exchange Rate Adjustment | -- | -- | -- | -- | -- | |
| Additions / Reductions | -$23.1M | -$18.2M | -$52.2M | -$105.3M | -- | |
| Ending Cash (CF) | $183.6M | $57.8M | $49.7M | $43.6M | -- | |
| Levered Free Cash Flow | $5.8M | $2.5M | $1.3M | $902K | -- | |
| Period Ending | 2021-12-31 | 2022-12-31 | 2023-12-31 | 2024-12-31 | 2025-12-31 | |
|---|---|---|---|---|---|---|
| Net Income to Stockholders | $9.2M | $8.8M | $7.4M | $4.6M | -- | |
| Depreciation & Amoritzation | $1.6M | $1.6M | $1.7M | $1.6M | -- | |
| Stock-Based Compensation | $360K | $475K | $450K | $390K | -- | |
| Change in Accounts Receivable | $37K | -$866K | -$369K | -$19K | -- | |
| Change in Inventories | -- | -- | -- | -- | -- | |
| Cash From Operations | $7.7M | $8.4M | $7.3M | $3.9M | -- | |
| Capital Expenditures | $6.3M | $398K | $444K | $43K | $100K | |
| Cash Acquisitions | -- | -- | -- | -- | -- | |
| Cash From Investing | -$66.5M | -$183.9M | -$26.8M | -$3.9M | -- | |
| Dividends Paid (Ex Special Dividend) | $2M | $2M | $1.9M | $1.9M | -- | |
| Special Dividend Paid | ||||||
| Long-Term Debt Issued | -- | -- | $40M | -- | -- | |
| Long-Term Debt Repaid | -- | -- | -$43M | -$15M | -- | |
| Repurchase of Common Stock | $152K | $1.7M | $2.1M | $65K | -- | |
| Other Financing Activities | -- | -- | -- | -- | -- | |
| Cash From Financing | $48.6M | $49.8M | $11.3M | -$6M | -- | |
| Beginning Cash (CF) | -- | -- | -- | -- | -- | |
| Foreign Exchange Rate Adjustment | -- | -- | -- | -- | -- | |
| Additions / Reductions | -$10.2M | -$125.8M | -$8.1M | -$6M | -- | |
| Ending Cash (CF) | -- | -- | -- | -- | -- | |
| Levered Free Cash Flow | $1.4M | $8M | $6.9M | $3.9M | -- | |
| Period Ending | 2022-12-31 | 2023-12-31 | 2024-12-31 | 2025-12-31 | 2026-12-31 | |
|---|---|---|---|---|---|---|
| Net Income to Stockholders | $8.8M | $7.4M | $4.6M | $1.2M | -- | |
| Depreciation & Amoritzation | $207K | $414K | $415K | $389K | -- | |
| Stock-Based Compensation | $475K | $450K | $390K | $231K | -- | |
| Change in Accounts Receivable | -$866K | -$369K | -$19K | -$69K | -- | |
| Change in Inventories | -- | -- | -- | -- | -- | |
| Cash From Operations | $8.4M | $7.3M | $3.9M | $7.1M | -- | |
| Capital Expenditures | $398K | $444K | $43K | $100K | -- | |
| Cash Acquisitions | -- | -- | -- | -- | -- | |
| Cash From Investing | -$183.9M | -$26.8M | -$3.9M | -$9.3M | -- | |
| Dividends Paid (Ex Special Dividend) | $2M | $1.9M | $1.9M | $1.5M | -- | |
| Special Dividend Paid | $100K | -- | -- | -- | -- | |
| Long-Term Debt Issued | $43M | $40M | -- | -- | -- | |
| Long-Term Debt Repaid | -$0 | -$43M | -$15M | -$4K | -- | |
| Repurchase of Common Stock | $1.7M | $2.1M | $65K | -- | -- | |
| Other Financing Activities | -- | -- | -- | -- | -- | |
| Cash From Financing | $49.8M | $11.3M | -$6M | $59.7M | -- | |
| Beginning Cash (CF) | $536.8M | $341.5M | $471.7M | $43.6M | -- | |
| Foreign Exchange Rate Adjustment | -- | -- | -- | -- | -- | |
| Additions / Reductions | -$125.8M | -$8.1M | -$6M | $57.5M | -- | |
| Ending Cash (CF) | $411M | $333.3M | $465.7M | $131.5M | -- | |
| Levered Free Cash Flow | $8M | $6.9M | $3.9M | $7M | -- | |
Get SFBC Stock Alert
Signup to receive the latest stock alerts
Financial Ratios
SFBC
Sector
P/E ratio
15.92x
12.54x
PEG ratio
0.29x
0.32x
P/B ratio
0.96x
1.15x
Price / LTM sales
1.84x
1.86x
Growth Metrics
SFBC
Sector
Revenue growth
-4.06%
5.54%
Earnings growth
17.58%
11.36%
Revenue (5-year growth)
7.77%
8.68%
Earnings forecast
--
$0.64
Profitability
SFBC
Sector
Profitability FY 2025
--
--
Return on invested capital
5%
5.2%
Return on assets
0.68%
1.03%
Return on equity
6.74%
9.91%
Earnings Date
Last Earnings Date
Jan
27
Next Earnings Date
Apr
28
Estimated Next Earnings Date
Apr
28
Balance Sheet
SFBC
Sector
Total cash
$110.1M
$407.2M
Short term investments
$7.8M
$192.4M
Total assets
$1.1B
$3.1B
Long term debt
$21.5M
$59.4M
SEE THE 1% OF STOCKS YOU NEED TO OWN FOR MASSIVE RETURNS
GET BETTER TRADE IDEAS
Popular
Is Lumentum The Best Laser Stock to Buy?
Though certainly less well-known than the huge tech businesses that…
Is Planet Fitness Stock Undervalued?
Planet Fitness (NYSE:PLNT) has had a difficult 12 months, retreating…
Stock Ideas
Buy
57
Is NVDA Stock a Buy?
Market Cap: $4.6T
P/E Ratio: 65x
Buy
61
Is AAPL Stock a Buy?
Market Cap: $4T
P/E Ratio: 37x
Buy
53
Is GOOG Stock a Buy?
Market Cap: $3.9T
P/E Ratio: 30x
Alerts
Buy
67
PRLB alert for Feb 10
Proto Labs, Inc. [PRLB] is down 2.16% over the past day.
Sell
33
MSTR alert for Feb 10
Strategy, Inc. [MSTR] is up 2.59% over the past day.
Sell
10
MOH alert for Feb 10
Molina Healthcare, Inc. [MOH] is down 3% over the past day.
THE #1 STOCK ANALYSIS TOOL
TO MAKE SMARTER BUY AND SELL DECISIONS
Show me the best stock
